✉news HealthNutrition first seen 15 h ago, last 14 min ago, peak #3
Study links pre-diagnostic blood metabolites to triple-negative breast cancer risk
Original: Prospective analysis of pre-diagnostic untargeted plasma metabolomics and risk of triple-negative breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Researchers with the International Agency for Research on Cancer have published a prospective analysis using pre-diagnostic untargeted plasma metabolomics within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, examining whether blood metabolite profiles measured before diagnosis are associated with later risk of triple-negative breast cancer, a harder-to-treat subtype.
Why now: New findings on early biological markers for triple-negative breast cancer draw attention from the cancer research and public health community.
International Agency for Research on CancerEPIC cohorttriple-negative breast cancer
Rank over time, top of the chart is #1. 9 snapshots from 15 h ago to 14 min ago.
Evidence
- Prospective analysis of pre-diagnostic untargeted plasma metabolomics and risk of triple-negative breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) · International Agency for Research on Cancer (IARC)
API: https://socialmediatrends-api.osmike.com/v1/trends/615614